Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
复制标题
DOI:
10.1371/journal.pone.0062425
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Dorsey JF
中科院分区:
文献类型:
--
作者:
Joh DY;Sun L;Stangl M;Al Zaki A;Murty S;Santoiemma PP;Davis JJ;Baumann BC;Alonso-Basanta M;Bhang D;Kao GD;Tsourkas A;Dorsey JF
Successful treatment of brain tumors such as glioblastoma multiforme (GBM) is limited in large part by the cumulative dose of Radiation Therapy (RT) that can be safely given and the blood-brain barrier (BBB), which limits the delivery of systemic anticancer agents into tumor tissue. Consequently, the overall prognosis remains grim. Herein, we report our pilot studies in cell culture experiments and in an animal model of GBM in which RT is complemented by PEGylated-gold nanoparticles (GNPs). GNPs significantly increased cellular DNA damage inflicted by ionizing radiation in human GBM-derived cell lines and resulted in reduced clonogenic survival (with dose-enhancement ratio of ∼1.3). Intriguingly, combined GNP and RT also resulted in markedly increased DNA damage to brain blood vessels. Follow-up in vitro experiments confirmed that the combination of GNP and RT resulted in considerably increased DNA damage in brain-derived endothelial cells. Finally, the combination of GNP and RT increased survival of mice with orthotopic GBM tumors. Prior treatment of mice with brain tumors resulted in increased extravasation and in-tumor deposition of GNP, suggesting that RT-induced BBB disruption can be leveraged to improve the tumor-tissue targeting of GNP and thus further optimize the radiosensitization of brain tumors by GNP. These exciting results together suggest that GNP may be usefully integrated into the RT treatment of brain tumors, with potential benefits resulting from increased tumor cell radiosensitization to preferential targeting of tumor-associated vasculature.
登录
查看更多内容
DOI:
10.2217/nnm.09.21
发表时间:
2009-06
期刊:
Nanomedicine (London, England)
影响因子:
--
作者:
Goel R;Shah N;Visaria R;Paciotti GF;Bischof JC
通讯作者:
Bischof JC
影响因子:
16.6
作者:
Jin, Yongdong;Jia, Congxian;Huang, Sheng-Wen;O'Donnell, Matthew;Gao, Xiaohu
通讯作者:
Gao, Xiaohu
影响因子:
--
作者:
Baumann, Brian C.;Kao, Gary D.;Dorsey, Jay F.
通讯作者:
Dorsey, Jay F.
DOI:
10.1007/s10967-007-0230-1
发表时间:
2007-02-01
影响因子:
1.6
作者:
James, W. D.;Hirsch, L. R.;Payne, J. D.
通讯作者:
Payne, J. D.
影响因子:
4.9
作者:
Chattopadhyay, Niladri;Cai, Zhongli;Reilly, Raymond M.
通讯作者:
Reilly, Raymond M.